TD Cowen Out Positive on Relay Therapeutics (RLAY), Shares Up ~53%, 'we are constructive on Ph3 success based on today's data'
Tweet Send to a Friend
TD Cowen analyst Yaron Werber reiterated a Buy rating on Relay Therapeutics (NASDAQ: RLAY).The analyst comments "Our Take: RLY-2608 Impresses ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
